Medicine & Health

Researchers at the School of Medicine have identified four important signs and symptoms that signal an elevated risk of early-onset colorectal cancer. The incidence of colorectal cancer is rising in people under 50, making it important to recognize such signs.

A new study from the School of suggests that some dangerous bloodstream infections in premature infants may be caused by strains of bacteria already lurking in their gut microbiomes.

Scientists at the Center for Clinical Pharmacology have identified a potential pathway to pain relief that neither triggers addiction nor causes hallucinations.

Andrea Heredia is about to graduate with a master’s degree in public health from the Brown School. After graduation, she will work as a statistical data analyst at the School of Medicine.

Stress causes the levels of Alzheimer’s proteins to rise in females’ brains but not males’ brains, according to a new study in mice by researchers at the School of Medicine. This difference may contribute to women’s greater risk of developing Alzheimer’s disease.

Pamela K. Woodard, MD, a national leader in cardiothoracic imaging, has been named head of the Department of Radiology, director of the Mallinckrodt Institute of Radiology and the Elizabeth E. Mallinckrodt Professor of Radiology at the School of Medicine.

Dayna S. Early, MD, a professor at the School of Medicine, will receive the 2023 Distinguished Endoscopic Research Mentoring Award from the American Society for Gastrointestinal Endoscopy.

The pre-nursing program at University College gives School of Medicine employees and other working adults the academic foundation to enter a bachelor’s of nursing program. The program is flexible, feasible and for most university employees, free. 

Patrick White, MD, PhD, director of the Division of Palliative Medicine in the Department of Medicine at the School of Medicine, has been selected to receive the 2023 Josefina B. Magno Distinguished Hospice Physician Award from the American Academy of Hospice and Palliative Medicine.

A new drug has been approved by the Food and Drug Administration (FDA) for a rare, inherited form of amyotrophic lateral sclerosis (ALS). The drug — based in part on research conducted at the School of Medicine — slows the progression of the deadly, paralyzing disease.